Dermavant Sciences Ltd Uncategorized Contracts & Agreements
3 Contracts & Agreements
- Option Agreement, effective as of March 28, 2019, by and between Dermavant Sciences GmbH and Roivant Sciences GmbH (Filed With SEC on May 24, 2019)
- Capital Expenditure Letter Agreement, dated November 5, 2018, by and between Dermavant Sciences GmbH and GlaxoSmithKline (Filed With SEC on May 24, 2019)
- Amended and Restated Roivant Commitment Letter, dated as of April 12, 2019, by and between Dermavant Sciences GmbH, Roivant Sciences Ltd. and the Registrant (Filed With SEC on May 24, 2019)
